Ridazolol is a beta-adrenergic receptor (betaAR) antagonist. Ridazolol exhibits a high degree of selectivity for beta-1 adrenergic receptor (beta1AR) and possesses moderate intrinsic sympathomimetic activity (ISA). Ridazolol can competitively antagonize the relaxation effects induced by isoproterenol. Ridazolol is utilized in the research of cardiovascular diseases[1].
Molecular Weight:
373.23
CAS Number:
[83395-21-5]
Formula:
C15H18Cl2N4O3
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted